HK1180322A1 - Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd - Google Patents

Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd

Info

Publication number
HK1180322A1
HK1180322A1 HK13107621.7A HK13107621A HK1180322A1 HK 1180322 A1 HK1180322 A1 HK 1180322A1 HK 13107621 A HK13107621 A HK 13107621A HK 1180322 A1 HK1180322 A1 HK 1180322A1
Authority
HK
Hong Kong
Prior art keywords
copd
treatment
respiratory diseases
pyrimidine derivatives
pyrimidine
Prior art date
Application number
HK13107621.7A
Other languages
English (en)
Chinese (zh)
Inventor
．愛德華德斯
．庫拉古斯基
．芬馳
Original Assignee
奇斯藥製品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇斯藥製品公司 filed Critical 奇斯藥製品公司
Publication of HK1180322A1 publication Critical patent/HK1180322A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
HK13107621.7A 2010-03-12 2013-06-28 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd HK1180322A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1004178.8A GB201004178D0 (en) 2010-03-12 2010-03-12 Enzyme inhibitors
PCT/GB2011/050477 WO2011110858A1 (en) 2010-03-12 2011-03-10 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd

Publications (1)

Publication Number Publication Date
HK1180322A1 true HK1180322A1 (en) 2013-10-18

Family

ID=42261512

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107621.7A HK1180322A1 (en) 2010-03-12 2013-06-28 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd

Country Status (16)

Country Link
US (1) US9156844B2 (xx)
EP (1) EP2545056B1 (xx)
JP (1) JP6065180B2 (xx)
KR (1) KR20130018671A (xx)
CN (1) CN102858774B (xx)
AU (1) AU2011225902B2 (xx)
BR (1) BR112012022879A2 (xx)
CA (1) CA2792725C (xx)
GB (1) GB201004178D0 (xx)
HK (1) HK1180322A1 (xx)
IL (1) IL221873A (xx)
MX (1) MX2012010004A (xx)
RU (1) RU2581839C2 (xx)
SG (1) SG184012A1 (xx)
UA (1) UA109000C2 (xx)
WO (1) WO2011110858A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2622643C2 (ru) * 2011-09-14 2017-06-19 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные тетрагидротриазолопиримидина в качестве ингибиторов нейтрофильной эластазы человека
DK2935274T3 (en) * 2012-12-18 2018-11-26 Chiesi Farm Spa 3-OXO-2,3,5,8-TETRAHYDRO- [1,2,4] TRIAZOLO [4,3-A] PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF AIR TRACT
US20140221335A1 (en) 2013-02-06 2014-08-07 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9115093B2 (en) 2013-03-04 2015-08-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
KR20160097227A (ko) 2013-12-16 2016-08-17 키에시 파르마슈티시 엣스. 피. 에이. 인간 호중구 엘라스타제 억제제로서 테트라하이드로트리아졸로피리미딘 유도체
USRE47493E1 (en) 2014-02-20 2019-07-09 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9487528B2 (en) 2014-06-09 2016-11-08 Chiesi Farmaceutici S.P.A. Compounds
WO2015188866A1 (en) * 2014-06-12 2015-12-17 Chiesi Farmaceutici S.P.A. Novel compounds
US9458113B2 (en) 2014-07-31 2016-10-04 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9290457B2 (en) 2014-07-31 2016-03-22 Boehringer Ingelheim International Gmbh Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9475779B2 (en) 2014-07-31 2016-10-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9657015B2 (en) 2014-07-31 2017-05-23 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9440930B2 (en) 2014-07-31 2016-09-13 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
AR106958A1 (es) 2015-12-14 2018-03-07 Chiesi Farm Spa Derivados de tetrahidrotriazolopirimidina útiles como inhibidores de hne
US9802919B1 (en) 2016-05-31 2017-10-31 Chiesi Farmaceutici S.P.A. Compounds
AR108609A1 (es) 2016-05-31 2018-09-05 Chiesi Farm Spa Derivados de imidazolona y pirazolona como inhibidores de la elastasa de neutrófilos humana (hne)
EP3464268B1 (en) 2016-05-31 2020-03-11 Chiesi Farmaceutici S.p.A. Novel compounds
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
IL297211A (en) 2020-04-16 2022-12-01 Mereo Biopharma 4 Ltd Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis
AR128053A1 (es) 2021-12-22 2024-03-20 Chiesi Farm Spa Sal derivada de triazolona como inhibidor de elastasa de neutrófilos
WO2023118258A1 (en) 2021-12-22 2023-06-29 Chiesi Farmaceutici S.P.A. Triazolone derivative salt as neutrophil elastase inhibitor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
AU2003255492A1 (en) * 2002-09-10 2004-04-30 Bayer Healthcare Ag Heterocyclic derivatives
GB0502258D0 (en) * 2005-02-03 2005-03-09 Argenta Discovery Ltd Compounds and their use
GB0520743D0 (en) * 2005-10-12 2005-11-23 Argenta Discovery Ltd Compounds and their use
WO2009013444A1 (en) * 2007-07-25 2009-01-29 Argenta Discovery Limited Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
GB0608844D0 (en) * 2006-05-04 2006-06-14 Argenta Discovery Ltd Enzyme inhibitors
BRPI0711169A2 (pt) * 2006-05-04 2011-08-23 Argenta Discovery Ltd tetrahidropirrolopiridinadionas e seu uso como inibidores de elastase neutrófilo humano
US20100010024A1 (en) * 2006-07-01 2010-01-14 Bayer Healthcare Ag Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension
DE102006031314A1 (de) * 2006-07-01 2008-01-03 Bayer Healthcare Aktiengesellschaft Verwendung von 1,4-Diaryl-dihydropyrimidin-2-on-Derivaten zur Behandlung der pulmonalen arteriellen Hyptertonie
DE102008022521A1 (de) * 2008-05-07 2009-11-12 Bayer Schering Pharma Aktiengesellschaft 1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung
KR101649381B1 (ko) * 2007-12-20 2016-08-19 바이엘 인텔렉쳐 프로퍼티 게엠베하 ４-(４-시아노-２-티오아릴)디히드로피리미디논 및 그의 용도
DE102009004197A1 (de) * 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung
GB201004179D0 (en) * 2010-03-12 2010-04-28 Pulmagen Therapeutics Inflamma Enzyme inhibitors

Also Published As

Publication number Publication date
JP2013522182A (ja) 2013-06-13
WO2011110858A1 (en) 2011-09-15
KR20130018671A (ko) 2013-02-25
CN102858774B (zh) 2015-05-06
EP2545056A1 (en) 2013-01-16
AU2011225902A1 (en) 2012-10-04
RU2012138579A (ru) 2014-04-20
US20130150380A1 (en) 2013-06-13
UA109000C2 (uk) 2015-07-10
US9156844B2 (en) 2015-10-13
SG184012A1 (en) 2012-10-30
BR112012022879A2 (pt) 2016-06-14
GB201004178D0 (en) 2010-04-28
EP2545056B1 (en) 2017-09-06
CA2792725A1 (en) 2011-09-15
JP6065180B2 (ja) 2017-01-25
AU2011225902B2 (en) 2015-11-05
IL221873A (en) 2016-05-31
CA2792725C (en) 2018-01-02
CN102858774A (zh) 2013-01-02
RU2581839C2 (ru) 2016-04-20
MX2012010004A (es) 2012-10-05

Similar Documents

Publication Publication Date Title
HK1180320A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
HK1180322A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
IL232256A0 (en) Purine derivatives and their use in the treatment of diseases
AP3807A (en) Novel heterocyclic derivatives and their use in the treatment of neurological disorders
IL227689A0 (en) The history of aza-indole, their preparation and their use in the treatment of diseases
ZA201109384B (en) Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
PT3042910T (pt) 2'-espiro-nucleósidos para utilização na terapia da hepatite c
ZA201308746B (en) Quinazoline derivatives for the treatment of viral infections and further diseases
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
IL223241A0 (en) Cysteamine derivatives and their use in the treatment of nash
EP2621279A4 (en) CONDENSED TETRACYCLIC DERIVATIVES AND METHODS OF USE THEREOF IN THE TREATMENT OF VIRAL DISEASES
PL2898885T3 (pl) Pochodne pirolopirymidynowe do zastosowania w leczeniu zakażeń wirusowych
EP2621501A4 (en) POLYCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS FOR THEIR USE IN THE TREATMENT OF VIRAL DISEASES
IL223286A0 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
HK1164369A1 (en) Preparation of microvesicle-sirna composition and use of the same in aids treatment
EP2740729A4 (en) QUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND, AND USE OF THE DERIVATIVE IN THE PREPARATION OF A MEDICAMENT
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
ZA201402452B (en) Novel pyrimethanil formulations and uses thereof in the treatment of crops
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
EP2744786A4 (en) SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER
HK1214771A1 (zh) 用於治療皮膚病的製劑
ZA201401800B (en) Novel plant defensins and use in the treatment of proliferative diseases
HUE038120T2 (hu) Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200308